Medicus pharma ltd. announces minor use (mums) designation from the fda for doxorubicin-containing microneedle array (d-mna) patch

Company to submit product development plan to treat external squamous cell carcinoma (scc) in horses company to submit product development plan to treat external squamous cell carcinoma (scc) in horses

ARRY Ratings Summary

ARRY Quant Ranking